2,770
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

The attributable annual health costs of U.S. occupational lead poisoning

References

  • Centers for Disease Control. Blood lead levels in children aged 1–5 years – United States, 1999–2010. Morb Mortal Wkly Rep. 2013 Apr 5;62(1):245–8.
  • Luo J, Hendryx M. Relationship between blood cadmium, lead, and serum thyroid measures in US adults – the National Health and Nutrition Examination Survey (NHANES) 2007–2010. Int J Environ Health Res. 2014(2);24:125–36.10.1080/09603123.2013.800962
  • Baker EL, Folland DS, Taylor TA, Frank M, Peterson W, Lovejoy G, et al. Lead poisoning in children of lead workers: home contamination with industrial dust. N Engl J Med. 1977 Feb 3;296(5):260–1.10.1056/NEJM197702032960507
  • Whelan EA, Piacitelli GM, Gerwel B, Schnorr TM, Mueller CA, Gittleman J, et al. Elevated blood lead levels in children of construction workers. Am J Public Health. 1997 Aug;87(8):1352–5.10.2105/AJPH.87.8.1352
  • Morb Mortal Wkly Rep. Take-home lead exposure among children with relatives employed at a battery recycling facility – Puerto Rico. 2011 Nov 30, 2012;61(47):967–70.
  • Newman N, Jones C, Page E, Ceballos D, Oza A. Investigation of childhood lead poisoning from parental take-home exposure from an electronic scrap recycling facility — Ohio, 2012. Morb Mort Weekly Rpt 2015 Jul 17:64(27);743–5.
  • Oliver T. Lead poisoning: from the industrial, medical and social points of view. New York (NY): PB Hoebner; 1914.
  • Holt LE. Lead poisoning in infancy. Am J Dis Child. 1923;25:229–33.
  • EPA 2008. National Ambient Air Quality Standard for Lead. 73 FR 66964; 2008 Nov 12.
  • National Institute of Environmental Health Sciences, National Toxicology Program. Health Effects of Low-Level Lead. 2012. Available from: http://ntp.niehs.nih.gov/ntp/ohat/lead/final/monographhealtheffectslowlevellead_newissn_508.pdf
  • California Department of Public Health; Occupational Lead Poisoning Prevention Program. Blood lead levels in California workers, 2008–2011. 2013. [cited 2013 Jun 5]. Available from: https://www.cdph.ca.gov/programs/olppp/Documents/CABLLReport.pdf
  • California Department of Public Health; Occupational Lead Poisoning Prevention Program. Memo: kJ Billingsley to JJ Sum. Health-based permissible exposure limit for lead. 2013 Sept 30 – [cited 2014 Dec 26]. Available from: https://www.cdph.ca.gov/programs/olppp/Documents/LeadStdPELRec.pdf
  • EPA. EPA Integrated Science Assessment for Lead. EPA/600/R-10/075F. 2013 Jun. Available from: http://cfpub.epa.gov/ncea/isa/recordisplay.cfm?deid=255721
  • National Institute of Occupational Safety and Health. Adult Blood Lead Epidemiology & Surveillance (ABLES) Program Description. 2015. [cited 2016 Feb 26]. Available from: http://www.cdc.gov/niosh/topics/ables/description.html
  • Kerr P. Vast amount of fraud discovered in workers’ compensation system. New York Times. 12/29/91:1.
  • Reville RT, Bhattacharya J, Sager L. Measuring the economic consequences of workplace injuries. Am J Ind Med. 2001;40:452–463.10.1002/(ISSN)1097-0274
  • Michaels D. Fraud in the workers’ compensation system: origin and magnitude. Occup Med. 1998 Apr-Jun;13(2):439–442.
  • Boden LI, Spieler EA. The relationship between workplace injuries and workers’ compensation claims: the importance of system design. In: Victor RA, Carrubba LL, editors. Workers’ compensation: where have we come from? Where are we going? Cambridge (MA): Workers Compensation Research Institute; p. 215–234. 2010.
  • Morse TF, Dillon C, Warren N, Hall C, Hovey D. Capture-recapture estimation of unreported work-related musculoskeletal disorders in Connecticut. Am J Ind Med. 2001;39(6):636–642.10.1002/(ISSN)1097-0274
  • Boden LI. Capture-recapture estimates of the undercount of workplace injuries and illnesses: sensitivity analysis. Am J Ind Med. 2014 Oct;57(10):1090–9. doi:10.1002/ajim.22247. Epub 2013 Sep 10.
  • Boden LI, Ruser J. Choice of medical care provider, workers’ compensation “Reforms”, and workplace injuries. Rev Econ Statistics. 2003;4(85):923–929.10.1162/003465303772815826
  • Government Accounting Office. Enhancing OSHA’s Records Audit Process Could Improve the Accuracy of Worker Injury and Illness Data. GAO 10-10. 2009 Nov.
  • Wuellner SE, Bonauto DK. Exploring the relationship between employer recordkeeping and underreporting in the BLS Survey of Occupational Injuries and Illnesses. Am J Ind Med. 2014;57:1133–1143.10.1002/ajim.v57.10
  • Schwartz J, Pitcher H, Levin R, Ostro B, Nichols AL. Costs and benefits of reducing lead in gasoline: final regulatory analysis. US EPA 1985. Washington (DC); EPA-230-05-85-006.
  • Levin R. Reducing lead in drinking water: A benefit analysis. US EPA 1986. Washington (DC); EPA-230-09-86-019.
  • Schwartz J. Societal benefits of reducing lead exposure. Environ Res. 1994;66(1):105–124.10.1006/enrs.1994.1048
  • Gould E. Childhood lead poisoning: conservative estimates of the social and economic benefits of lead hazard control. Environ Health Perspect. 2009;117(7):1162–1167.10.1289/ehp.0800408
  • Muennig P. The social costs of childhood lead exposure in the post-lead regulation era. Arch Pediatr Adolesc Med. 2009;163(9):844–49.
  • Reyes JW. Social Cost of Lead. In: Lead: The Global Poison – Humans, Animals, and the Environment, a Symposium at the Annual Meeting of the American Association for the Advancement of Science Conference in Boston, MA, 2013 Feb.
  • EPA. Guidelines in preparing economic analyses. . National Center for Environmental Economics, Office of Policy. [updated 2014 May; 2010 Dec 17; cited 2015 Jan 5]. Available from: http://yosemite.epa.gov/ee/epa/eerm.nsf/vwAN/EE-0568-50.pdf/$file/EE-0568-50.pdf.
  • Kennedy School of Government, Health Care Delivery Policy Program. Healthcare Delivery – Deconstructing the Costs. 2007. [cited 2015 Aug 1]. Available from: http://www.ksg.harvard.edu/m-rcbg/hcdp/numbers/Deconstructing%20the%20Costs%20Summary.pdf.
  • Javitt JC, Zhou Z, Willke RJ. Association between vision loss and higher medical care costs in Medicare beneficiaries’ costs are greater for those with progressive vision loss. Ophthalmology. 2007 Feb;114(2):238–245.e1.10.1016/j.ophtha.2006.07.054
  • Cipriano LE, Romanus D, Earle CC, Neville BA, Halpern EF, Gazelle GS, McMahon PM. Lung cancer treatment costs, including patient responsibility, by stage of disease and treatment modality, 1992–2003. Value Health. 2011 Jan;14(1):41–52. doi:10.1016/j.jval.2010.10.006.
  • Ginsburg PB. Center for Studying Health System Change. Wide variation in hospital and physician payment rates evidence of provider market power. HSC Research Brief No. 16. http://www.hschange.com/CONTENT/1162/. November 2010. [cited 2013 May 17]. Available from: http://www.ajmc.com/publications/issue/2014/2014-vol20-n11/variation-in-hospital-inpatient-prices-across-small-geographic-areas/3#sthash.fBdrffzR.dpuf
  • Maeda JL, Mosher Henke R, Marder WD, Karaca Z, Friedman BS, Wong, HS. Variation in hospital inpatient prices across small geographic areas. Am J Manag Care. 2014 Nov;20(11):907–16. [cited 2014 Dec 12]. http://www.ajmc.com/publications/issue/2014/2014-vol20-n11/variation-in-hospital-inpatient-prices-across-small-geographic-areas/2#sthash.YRib7Bzx.dpuf
  • Coughlin TA, Holahan J, Caswell K, McGrath M. Uncompensated care for the uninsured in 2013: a detailed examination. Henry J. Kaiser Family Foundation; 2014 May 30.
  • Troy TD, Wilson DM. Health coverage cost per covered life: Government vs. employment- sponsored programs. American Health Policy Institute; 2014. Available from: http://www.americanhealthpolicy.org/Content/documents/resources/AHPI_STUDY_Cost_Per_Covered_Life.pdf
  • Weil D. Valuing the economic consequences of work injury and illness: a comparison of methods and findings. Am J Ind Med. 2001;40:418–437.10.1002/(ISSN)1097-0274
  • Cubanski J, Swoope C, Damico A, Neuman T. How much is enough? Out-of-pocket spending among Medicare beneficiaries: a chartbook. Kaiser Family Foundation. 2014 Jul 21; [cited 2015 Apr 19]. Available from: http://kff.org/health-costs/report/how-much-is-enough-out-of-pocket-spending-among-medicare-beneficiaries-a-chartbook/.
  • Health Pocket InfoStat. Obamacare rate filings reveal changes in out-of-pocket costs. 7-14-14. Written by Coleman K and Geneson J. [cited 2015 Apr 19]. Available from: http://www.healthpocket.com/healthcare-research/infostat/2015-obamacare-out-of-pocket-preview#.VU5S7U0rjcu
  • MEPS (Medical Expenditure Panel Survey), Department of Health and Human Services, AHRQ. Table 4: Total Expenses and Percent Distribution for Selected Conditions by Source of Payment: United States, 2012. [cited 2013 Nov 26]. Available from: http://meps.ahrq.gov/mepsweb/data_stats/tables_compendia_hh_interactive.jsp?_SERVICE=MEPSSocket0&_PROGRAM=MEPSPGM.TC.SAS&File=HCFY2012&Table=HCFY2012%5FCNDXP%5FD&_Debug=
  • Boden Li, Biddle EA, Spieler EA. Social and economic impacts of workplace illness and injury: Current and future directions for research. Am J Ind Med. 2001 Oct;40(4):398–402.10.1002/(ISSN)1097-0274
  • Reville RT. The impact of a disabling workplace injury on earnings and labor force participation. In: Haltiwanger J, Lane J, Spletzer J, Theeuwes J, Troske K, editors. The creation and analysis of linked employer-employee data, contributions to economic analysis. New York, NY: Elsevier Science, North Holland; p. 147–173.1999.
  • Kosnett MJ, Wedeen RP, Rothenberg SJ, Hipkins KL, Materna BL, Schwartz BS, et al. Recommendations for medical management of adult lead exposure. Environ Health Perspect. 2007;115:463–471. doi:10.1289/ehp.9784.
  • Bureau of Labor Statistics, U.S. Department of Labor. The Economics Daily. 2015. Occupational employment and wages in 2014. Available from: http://www.bls.gov/opub/ted/2015/occupational-employment-wages-2014.htm ( visited 2015 Jul 19).
  • Hartvigsen J, Davidsen M, Sogaard K, Roos EM, Hestbaek L. Self-reported musculoskeletal pain predicts long-term increase in general health care use: a population-based cohort study with 20-year follow-up. Scand J Public Health. 2014 Nov;42(7):698–704. doi:10.1177/1403494814542263. Epub 2014 Jul 22.
  • Yelin E, Herrndorf A, Trupin L, Sonneborn D. A national study of Medical Care Expenditures for musculoskeletal conditions, the impact of health insurance and managed care. Arthritis & Rheumatism. 2001;44(5):1160–9.
  • Frick KD, Gower EW, Kempen JH, Wolff JL. Economic impact of visual impairment and blindness in the United States. Arch Ophthalmol. 2007 Apr;125(4):544–50.10.1001/archopht.125.4.544
  • Pratt LA, Brody DJ. Depression in the United States household population, 2005–2006. National Center for Health Statistics: NCHS Data Brief No. 7; 2008. Available from: http://www.cdc.gov/nchs/data/databriefs/db07.htm#ref08
  • Welch CA, Czerwinski D, Ghimire B, Bertsimas D. Depression and costs of health care. Psychosomatics. 2009;50(4):392–401.10.1176/appi.psy.50.4.392
  • Luppa M, Heinrich S, Angermeyer MC, König H-H, Riedel-Heller SG. Cost-of-illness studies of depression: a systematic review. J Affective Disorders. 2007;98:29–43.10.1016/j.jad.2006.07.017
  • Shirneshan E, Bailey J, Relyea G, Franklin BE, Solomon DK, Brown LM. Incremental direct medical expenditures associated with anxiety disorders for the U.S. adult population: evidence from the Medical Expenditure Panel Survey. J Anxiety Disord. 2013 Oct;27(7):720–7. doi:10.1016/j.janxdis.2013.09.009. Epub 2013 Sep 25.
  • Stuhldreher N, Leibing E, Leichsenring F, Beutel ME, Herpertz S, Hoyer J, et al. The costs of social anxiety disorder: the role of symptom severity and comorbidities. J Affect Disord. 2014 Aug;165:87–94. doi:10.1016/j.jad.2014.04.039. Epub 2014 Apr 24.
  • Noyes K, Liu H, Li Y, Holloway R, Dick AW. Economic burden associated with Parkinson’s disease on elderly Medicare beneficiaries. Mov Disord. 2006 Mar;21(3):362–72.10.1002/mds.20727
  • Hurd MD. The monetary costs of dementia in the United States. Rand Corporation, presentation to the Senate Appropriations Committee, Subcommittee on Labor, Health and Human Services. 2014 Feb 26.
  • Alzheimer’s Association. Alzheimer’s disease Facts and Figures. Alzheimer’s and Dementia. 2014. 10(2):40–53.
  • Alzheimer’s Association. Stages of Alzheimer’s. 2015. [cited 2015 Aug 2]. Available from: http://www.alz.org/alzheimers_disease_stages_of_alzheimers.asp
  • Neumann PJ, Gharib SD, Weinstein MC. The cost of a successful delivery with in vitro fertilization. N Engl J Med. 1994 Jul 28;331(4):239–43.10.1056/NEJM199407283310406
  • Goldfarb JM, Austin C, Lisbona H, Peskin B, Clapp M. Cost-effectiveness of in vitro fertilization. Obstet Gynecol. 1996 Jan;87(1):18–21.10.1016/0029-7844(95)00345-2
  • Wu AK, Odisho AY, Washington SL 3rd, Katz PP, Smith JF. Out-of-pocket fertility patient expense: data from a multicenter prospective infertility cohort. J Urol. 2014 Feb;191(2):427–32. doi:10.1016/j.juro.2013.08.083. Epub 2013 Sep 7.
  • Behrman RE, Butler AS, editors. Preterm birth: causes, consequences, and prevention. Institute of Medicine (US) Committee on understanding premature birth and assuring healthy outcomes. Washington (DC): National Academies Press (US); 2007.
  • US Renal Data System. 2014 USRDS Annual Data Report. [cited 2014 Dec 30]. Available from: http://www.usrds.org/adr.aspx
  • US Renal Data System. 2012 Annual Data Report: Epidemiology of Kidney Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2014. [cited 2014 Dec 29]. Available from: USRDS.org/2012/pdf/v2_ch11_12.pdf. 2012. Costs of ESRD.
  • Kidney and Urologic Diseases Information Clearinghouse. Kidney disease statistics for the United States 2014. [cited 2014 Dec 26]. http://kidney.niddk.nih.gov/KUDiseases/pubs/kustats/
  • EPA. The Cost of Illness Handbook. 1997. [cited 2013 Jun 13]. Available from: http://yosemite.epa.gov/ee/epa/eed.nsf/1acac3896fc46b38852575a6006ab36a/a344d66cad70b0fb852575a7005e2c9f!opendocument
  • Van Houtven G, Honeycutt AA, Gilman B, McCall NT, Throneburg WW, Sykes KE. Costs of Illness for Six Major Health Conditions among Older Adults. November 30, 2004. Prepared by RTI International. (RTI International is a trade name of Research Triangle Institute.) for US EPA, Aging Initiative. [cited 2015 Jan 2]. Available from: http://www.epa.gov/research/aging/docs/2004-coi-paper.pdf
  • American Heart Association. Heart disease and stroke statistics – 2014 update: a report from the American Heart Association. Circulation. 2014;128:e2–e273.
  • Voigt J, Sasha John M, Taylor A, Krucoff M, Reynolds MR, Michael Gibson C. A reevaluation of the costs of heart failure and its implications for allocation of health resources in the United States. Clin Cardiol. 2014 May;37(5):312–21.10.1002/clc.22260
  • Ben-Josef G, Ott LS, Spivack SB, Wang C, Ross JS, Shah SJ, et al. Payments for acute myocardial infarction episodes-of-care initiated at hospitals with and without interventional capabilities. Circ Cardiovasc Qual Outcomes. 2014 Nov;7(6):882–8. doi:10.1161/CIRCOUTCOMES.114.000927. Epub 2014 Nov 11.
  • Afana M, Brinjikji W, Cloft H, Salka S. Hospitalization costs for acute myocardial infarction patients treated with percutaneous coronary intervention in the United States are substantially higher than medicare payments. Clin Cardiol. 2015;38(1):13–19. doi: 10.1002/clc.22341.
  • National Bureau of Economic Research. Economic benefits of health attack treatments outweigh the cost. [cited 2013 Jan 15]. http://www.nber.org/digest/oct98/w6514.html
  • Brilleman SL, Purdy S, Salisbury C, Windmeijer F, Gravelle H, Hollinghurst S. Implications of comorbidity for primary care costs in the UK: a retrospective observational study. Br J Gen Pract. 2013 Apr;63(609):274–82. doi:10.3399/bjgp13X665242.
  • Halpern MT, Zilberberg MD, Schmier JK, Lau EC, Shorr AF. Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc. 2006 Oct;4:17.10.1186/1478-7547-4-17
  • Smith RE Jr. The clinical and economic burden of anemia. Am J Manag Care. 2010 Mar; 16 Suppl Issues:S59–66. Review.
  • Nissenson AR, Wade S, Goodnough T, Knight K, Dubois RW. Economic burden of anemia in an insured population. J Manag Care Pharm. 2005 Sep;11(7):565–74.
  • Leigh JP, Seavey W, Leistikow B. Estimating the costs of job related arthritis. J Rheumatol. 2001 Jul;28(7):1647–1654.
  • Leigh JP, Cone JE, Harrison R. Costs of occupational injuries and illnesses in California. Prev Med. 2001 May;32(5):393–406.10.1006/pmed.2001.0841
  • Leigh JP. Economic burden of occupational injury and illness in the United States. Milbank Quarterly. 2011 Dec;89(4):728–72. doi:10.1111/j.1468-0009.2011.00648.x.
  • Leigh JP, Markowitz SB, Fahs M, Shin C, Landrigan PJ. Occupational injury and illness in the United States. Arch Intern Med. 1997 Jul 28;157(14):1557–68.10.1001/archinte.1997.00440350063006
  • Leigh JP, Romano PS, Schenker MB, Kreiss K. Costs of occupational COPD and asthma. Chest. 2002 Jan;121(1):264–72.10.1378/chest.121.1.264
  • EPA. Regulatory Impact Analysis of the Final Revisions to the National Ambient Air Quality Standards for Ground-Level Ozone. 2015. [cited 2016 Feb 26]. Available from: http://www3.epa.gov/ozonepollution/pdfs/20151001ria.pdf
  • OSHA. Background of cost estimates. 2015. [cited 2016 Feb 26]. Available from: https://www.osha.gov/dcsp/smallbusiness/safetypays/background.html
  • Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med. 2004 Apr;46:398–412.10.1097/01.jom.0000121151.40413.bd
  • Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290(18):2443–2454.10.1001/jama.290.18.2443
  • Carlson H, Carlson N. An overview of the management of persistent musculoskeletal pain. Ther Adv Musculoskel Dis. 2011;3(2):91–99.10.1177/1759720X11398742
  • Letvak SA, Ruhm CJ, Gupta SN. Nurses’ presenteeism and its effect on self-reported quality of care and costs. Am J of Nursing. 2012;112(2):30–38.
  • Pittig A, Brand M, Pawlikowski M, Alpers GW. The cost of fear: avoidant decision making in a spider gambling task. J Anxiety Disord. 2014 Apr;28(3):326–34. doi:10.1016/j.janxdis.2014.03.001. Epub 2014 Mar 12.
  • Whetten-Goldstein K, Sloan F, Kulas E, Cutson T, Schenkman M. The burden of Parkinson’s disease on society, family, and the individual. J Am Geriatr Soc. 1997 Jul;45(7):844–9.10.1111/jgs.1997.45.issue-7
  • Rubenstein LM, DeLeo A, Chrischilles EA. Economic and health-related quality of life considerations of new therapies in Parkinson’s disease. PharmacoEconomics. 2001;19(7):729–52.10.2165/00019053-200119070-00003
  • Wu AK, Elliott P, Katz PP, Smith JF. Time costs of fertility care: the hidden hardship of building a family. Fertil Steril. 2013 Jun;99(7):2025–30. doi:10.1016/j.fertnstert.2013.01.145. Epub 2013 Feb 28.
  • National Institute for Occupational Safety and Health. Workers Health Chartbook 2004. NIOSH Publication No. 2004-146. Washington (DC). Available from: http://www.cdc.gov/niosh/docs/2004-146/ch2/ch2-6.asp.htm
  • Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015 Feb;76(2):155–162. doi:10.4088/JCP.14m09298.
  • Valenstein M, Vijan S, Zeber JE, Boehm K, Buttar A. The cost–utility of screening for depression in primary care. Ann Intern Med. 2001;134:345–360.10.7326/0003-4819-134-5-200103060-00007
  • Huse DM, Schulman K, Orsini L, Castelli-Haley J, Kennedy S, Lenhart G. Burden of illness in Parkinson’s disease. Mov Disord. 2005 Nov;20(11):1449–54.10.1002/(ISSN)1531-8257
  • Alarcon WA. Elevated blood lead levels among employed adults – United States, 1994–2012. Morb Mort Wkly Rpt. 2015;62(54):52–75.
  • Åkesson A, Lundh T, Vahter M, Bjellerup P, Lidfeldt J, Nerbrand C, et al. Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ Health Perspect. 2005;113:1627–1631.10.1289/ehp.8033
  • Clase C Renal failure (chronic). Clin Evid (Online) 2009. [Published online Oct 26; cited 2010 Aug 30].
  • Navas-Acien A, Tellez-Plaza M, Guallar E, Muntner P, Silbergeld E, Jaar B, et al. Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am J Epidemiol. 2009 Nov 1;170(9):1156–64. doi:10.1093/aje/kwp248. Epub 2009 Aug 21.
  • Jain NB, Potula V, Schwartz J, Vokonas PS, Sparrow D, Wright RO, et al. Lead levels and ischemic heart disease in a prospective study of middle-aged and elderly men: the VA normative aging study. Environ Health Perspectives. 2007;115(6):871–875.10.1289/ehp.9629
  • Centers for Disease Control. National Vital Statistics Reports, vol 61, No. 6 10/10/12. Deaths: Preliminary Data for 2011. Hoyert DL and Xu J.
  • Cheng Y, Schwartz J, Sparrow D, Aro A, Weiss ST, Hu H. Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension the normative aging study. Am J Epidemiol. 2001;153(2):164–171.10.1093/aje/153.2.164
  • Behinaein S, Chettle DR, Egden LM, McNeill FE, Norman G, Richard N, et al. Nonlinearity in the relationship between bone lead concentrations and CBLI for lead smelter employees. J Environ Monit. 2012 Dec;14(12):3267–75. doi:10.1039/c2em30652b. Epub 2012 Nov 14.
  • Davila EP, Kuklina EV, Valderrama AL, Yoon PW, Rolle I, Nsubuga P. Prevalence, management, and control of hypertension among US workers: does occupation matter? J Occup Environ Med. 2012. http://www.cdc.gov/dhdsp/pubs/docs/SIB_Hypertension_Workers.pdf
  • Weisskopf MG, Jain N, Nie H, Sparrow D, Vokonas P, Schwartz J, et al. A prospective study of bone lead concentration and death from all causes, cardiovascular diseases, and cancer in the department of veterans affairs normative aging study. Circulation. 2009;120(12):1056–64.10.1161/CIRCULATIONAHA.108.827121
  • Zhu M, Fitzgerald EF, Gelberg KH, Lin S, Druschel CM. Maternal low-level lead exposure and fetal growth. Environ Health Persp. 2010;118(10):1471–5.10.1289/ehp.0901561
  • Leigh JP, Markowitz S, Fahs M, Landrigan P. Costs of Occupational Injuries and Illnesses. Ann Arbor: U Mich Press; 2000. p. 67.
  • Seabury SA, Scherer E, O’Leary P, Ozonoff A, Boden L. Using linked federal and state data to study the adequacy of workers’ compensation benefits. Am J Ind Med. 2014 Oct;57(10):1165–73. doi:10.1002/ajim.22362.
  • Charnow JA. Dialysis Patient Death Rate Continues to Drop. Renal and Urology News, 2014 Jan 3. Available from: http://www.renalandurologynews.com/dialysis-patient-death-rate-continues-to-drop/article/327727/. Accessed 3/9/15.
  • Ortman JM, Velkoff VA, Hogan H. An aging nation: the older population in the United States, population estimates and projections. U.S. Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau. 2014 May. P25-1140. [ cited 2015 Mar 9]. Available from: http://www.census.gov/prod/2014pubs/p25-1140.pdf
  • US Census Bureau. Industry General Summary: 2002 Construction. 2002 Economic Census, 2005 Oct. Washington (DC).
  • EPA. Economic Analysis for the TSCA Lead Renovation, Repair, and Painting Program Final Rule for Target Housing and Child-Occupied Facilities. 2008. Available from: http://www.nchh.org/Portals/0/Contents/EPA-HQ-OPPT-2005-0049-0916_Final_Economic_Analysis_3-08.pdf
  • EPA. Federal Lead-Based Paint Program Database (FLPP), recorded about 128,000 firms as of May 1, 2015. [cited 2015 Aug 17]. Accessed from: https://cfext.epa.gov/flpp/
  • Keogh JP, Nuwayhid I, Gordon JL, Gucer PW. The impact of occupational injury on the injured worker and family: outcomes of upper extremity cumulative trauma disorders in Maryland workers. Am J Ind Med. 2000;38(5):498–506.10.1002/1097-0274(200011)38:5<>1.0.CO;2-H
  • ACS (American Cancer Society Cancer Action Network). New Study Reveals Popular Federal Employee Health Plan a Good Starting Point to Determine Minimum Benefits Coverage. [cited 2013 Jan 15]. http://action.acscan.org/site/News2?page=NewsArticle&id=11253&news_iv_ctrl=1321
  • Meng MV, Greene KL, Turek PJ. Surgery or assisted reproduction? A decision analysis of treatment costs in male infertility. J Urol. 2005 Nov;174(5):1926–31; discussion 1931.10.1097/01.ju.0000176736.74328.1a
  • Pratt KT. Inconceivable? Deducting the costs of fertility treatment. Cornell Law Review. 2004 Jul;89(5):1121–200.